JP2011063520A5 - - Google Patents

Download PDF

Info

Publication number
JP2011063520A5
JP2011063520A5 JP2009213095A JP2009213095A JP2011063520A5 JP 2011063520 A5 JP2011063520 A5 JP 2011063520A5 JP 2009213095 A JP2009213095 A JP 2009213095A JP 2009213095 A JP2009213095 A JP 2009213095A JP 2011063520 A5 JP2011063520 A5 JP 2011063520A5
Authority
JP
Japan
Prior art keywords
skin
heparanase
whitening
activity
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009213095A
Other languages
English (en)
Japanese (ja)
Other versions
JP5685369B2 (ja
JP2011063520A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009213095A priority Critical patent/JP5685369B2/ja
Priority claimed from JP2009213095A external-priority patent/JP5685369B2/ja
Publication of JP2011063520A publication Critical patent/JP2011063520A/ja
Publication of JP2011063520A5 publication Critical patent/JP2011063520A5/ja
Application granted granted Critical
Publication of JP5685369B2 publication Critical patent/JP5685369B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009213095A 2009-09-15 2009-09-15 ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法 Active JP5685369B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009213095A JP5685369B2 (ja) 2009-09-15 2009-09-15 ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009213095A JP5685369B2 (ja) 2009-09-15 2009-09-15 ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014192981A Division JP6321506B2 (ja) 2014-09-22 2014-09-22 ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法

Publications (3)

Publication Number Publication Date
JP2011063520A JP2011063520A (ja) 2011-03-31
JP2011063520A5 true JP2011063520A5 (https=) 2012-10-25
JP5685369B2 JP5685369B2 (ja) 2015-03-18

Family

ID=43950153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009213095A Active JP5685369B2 (ja) 2009-09-15 2009-09-15 ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法

Country Status (1)

Country Link
JP (1) JP5685369B2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6757320B2 (ja) * 2014-12-29 2020-09-16 ベンタナ メディカル システムズ, インコーポレイテッド 多重化画像における血管解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042496A1 (en) * 2003-10-21 2005-05-12 Imclone Systems Incorporated (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
WO2009122540A1 (ja) * 2008-03-31 2009-10-08 株式会社資生堂 しわを防止または改善するための経口、注射、皮膚外用剤および美容方法
KR20160003188A (ko) * 2008-03-31 2016-01-08 가부시키가이샤 시세이도 주름을 방지 또는 개선하기 위한 경구, 주사, 피부 외용제 및 미용 방법
EP2484359B1 (en) * 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
JP2011184308A (ja) * 2010-03-04 2011-09-22 Shiseido Co Ltd 皮膚外用剤

Similar Documents

Publication Publication Date Title
EP2422796A3 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
EA201100242A1 (ru) Образующие тонкий слой жидкие композиции для высвобождения лекарственных веществ в кожу и волосяной покров головы
WO2010101742A3 (en) Ampholytic ter-polymers for use in personal care compositions
ZA201104600B (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
EP2019316A3 (en) Ex vivo human skin model
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
JP6009791B2 (ja) Hdc活性化阻害剤、hdc活性化阻害剤組成物、鎮痒剤及び鎮痒剤組成物
WO2012160289A3 (fr) Composition cosmétique comprenant un polymère superabsorbant et un glucide choisi parmi les oses, les oligosides et les homopolyholosides
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
ATE418959T1 (de) Topische zusammensetzun mit natrium hyaluronat fragmente und einen retinoid
WO2016065688A1 (zh) 一种能激活肌肤活力和抗衰老的精华液
SG169995A1 (en) External preparation for skin containing flavanone derivative
ATE394125T1 (de) Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe
CN104352384A (zh) 具有抗衰老功效的精华液
FR2948564B1 (fr) Utilisation de n- hexadecanoyl isoleucine pour reguler l'activite des cellules presentes dans le tissu adipeux de l'hypoderme de la peau humaine
JP2011063520A5 (https=)
ATE461691T1 (de) Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung
FR2935379B1 (fr) Utilisation de n-acyl aminoacides comme principe actifs cosmetiques et pharmaceutiques, regulateurs de la proportion de keratinocytes basaux de l'epiderme de la peau humaine exprimant la forme nucleaire de la survivine ; compositions
WO2013087665A3 (en) Composition comprising a carboxylated fructan for epidermis hydratation
ATE462477T1 (de) Verwendung eines quinoa-extrakts als kosmetisches und pharmazeutisches schlankheitsmittel und/oder als mittel zur verhinderung der formierung neuer fette im menschlichen körper
CN105496837A (zh) 一种修复眼霜
CN105496836A (zh) 一种功能型抗老化面膜
CN103976929A (zh) 一种具有iPS活细胞液和生物多肽美白的化妆品
WO2012140609A3 (en) System for prolonged release of cosmetic agents
Morganti et al. Activity of Chitin Nanofibrils block-copolymers entrapping Zn/Al/SA/Allantoin on Seborrheic Dermatitis. A randomized double-blind placebo controlled study